Zobrazeno 1 - 10
of 182
pro vyhledávání: '"Sandanayake N"'
Autor:
Blackburn C; Discipline of Speech Pathology, Faculty of Health, University of Canberra, Canberra, Australia., Tueres M; Discipline of Speech Pathology, Faculty of Health, University of Canberra, Canberra, Australia., Sandanayake N; Discipline of Speech Pathology, Faculty of Health, University of Canberra, Canberra, Australia., Roberts J; Autism Centre of Excellence, Griffith University, Nathan, Australia., Sutherland R; Discipline of Speech Pathology, Faculty of Health, University of Canberra, Canberra, Australia.; Discipline of Speech Pathology, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Publikováno v:
International journal of language & communication disorders [Int J Lang Commun Disord] 2023 Nov-Dec; Vol. 58 (6), pp. 1977-1993. Date of Electronic Publication: 2023 Jul 18.
Autor:
Nahar KJ; Melanoma Institute Australia.; Faculty of Medicine and Health.; Charles Perkins Centre, and., Marsh-Wakefield F; Faculty of Medicine and Health.; Charles Perkins Centre, and.; Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia., Rawson RV; Melanoma Institute Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Gide TN; Melanoma Institute Australia.; Faculty of Medicine and Health.; Charles Perkins Centre, and., Ferguson AL; Faculty of Medicine and Health.; Charles Perkins Centre, and.; Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia., Allen R; Faculty of Medicine and Health.; Charles Perkins Centre, and., Quek C; Melanoma Institute Australia.; Faculty of Medicine and Health.; Charles Perkins Centre, and., da Silva IP; Melanoma Institute Australia.; Faculty of Medicine and Health.; Charles Perkins Centre, and., Tattersal S; Royal North Shore Hospital, Sydney, New South Wales Australia., Kiely CJ; Royal North Shore Hospital, Sydney, New South Wales Australia., Sandanayake N; Royal North Shore Hospital, Sydney, New South Wales Australia., Carlino MS; Melanoma Institute Australia.; Crown Princess Mary Cancer Centre and Westmead Hospitals, New South Wales, Australia., McCaughan G; Faculty of Medicine and Health.; Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia., Wilmott JS; Melanoma Institute Australia.; Faculty of Medicine and Health.; Charles Perkins Centre, and., Scolyer RA; Melanoma Institute Australia.; Faculty of Medicine and Health.; Charles Perkins Centre, and.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Long GV; Melanoma Institute Australia.; Faculty of Medicine and Health.; Royal North Shore Hospital, Sydney, New South Wales Australia.; Mater Hospital, North Sydney, New South Wales, Australia., Menzies AM; Melanoma Institute Australia.; Faculty of Medicine and Health.; Royal North Shore Hospital, Sydney, New South Wales Australia.; Mater Hospital, North Sydney, New South Wales, Australia., Palendira U; Melanoma Institute Australia.; Faculty of Medicine and Health.; Charles Perkins Centre, and.
Publikováno v:
JCI insight [JCI Insight] 2022 Nov 08; Vol. 7 (21). Date of Electronic Publication: 2022 Nov 08.
Autor:
Kemp W; Alfred Hospital, Melbourne, VIC, Australia.; Monash University, Melbourne, VIC, Australia., Majeed A; Alfred Hospital, Melbourne, VIC, Australia.; Monash University, Melbourne, VIC, Australia., Mitchell J; Alfred Hospital, Melbourne, VIC, Australia., Majumdar A; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Tse E; Royal Adelaide Hospital, Adelaide, SA, Australia., Skoien R; Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia., Croagh D; Monash Medical Centre, Melbourne, VIC, Australia., Dev A; Monash Medical Centre, Melbourne, VIC, Australia., Gao H; Monash Medical Centre, Melbourne, VIC, Australia., Weltman M; Nepean Hospital, Sydney, NSW, Australia., Craig P; St George Hospital, Sydney, NSW, Australia., Stuart K; Greenslopes Private Hospital, Brisbane, QLD, Australia., Cheng W; Royal Perth Hospital, Perth, WA, Australia., Edmunds S; Royal Perth Hospital, Perth, WA, Australia., Lee E; Westmead Hospital, Sydney, NSW, Australia., Sood S; Royal Melbourne Hospital, Melbourne, VIC, Australia., Metz A; Royal Melbourne Hospital, Melbourne, VIC, Australia., Thompson A; St Vincent's Hospital, Melbourne, VIC, Australia., Sinclair M; Austin Health, Melbourne, VIC, Australia., Beswick L; Geelong Hospital, Geelong, VIC, Australia., Nicoll A; Eastern Health, Melbourne, VIC, Australia., Riordan S; Prince of Wales Hospital, Sydney, NSW, Australia., Braund A; Gold Coast University Hospital, Gold Coast, QLD, Australia., Muller K; Flinders Medical Centre, Adelaide, SA, Australia., MacQuillan G; Sir Charles Gairdner Hospital, Perth, WA, Australia., Sandanayake N; Royal North Shore Hospital, St Leonards, NSW, Australia., Shackel N; Liverpool Hospital, Sydney, NSW, Australia., Roberts SK; Alfred Hospital, Melbourne, VIC, Australia.; Monash University, Melbourne, VIC, Australia.
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2021 Dec; Vol. 41 (12), pp. 2934-2943. Date of Electronic Publication: 2021 Sep 03.
Autor:
Sandanayake, N S1, Sinclair, J2, Andreola, F3, Chapman, M H4, Xue, A5, Webster, G J4, Clarkson, A6, Gill, A6, Norton, I D7, Smith, R C5, Timms, J F2, Pereira, S P4
Publikováno v:
British Journal of Cancer. 10/25/2011, Vol. 105 Issue 9, p1370-1378. 9p. 1 Color Photograph, 4 Charts, 3 Graphs.
Autor:
Gordon E; Royal College of General Practitioners, 85 Tamar Street, Ballina, NSW, 2478, Australia. emmagordon1@hotmail.co.uk., Chan DL; Department of Medical Oncology, Royal North Shore Hospital, St. Leonards, Sydney, NSW, 2065, Australia., Arena J; Department of Medical Oncology, Royal North Shore Hospital, St. Leonards, Sydney, NSW, 2065, Australia., Bernard E; Department of Nuclear Medicine, Royal North Shore Hospital (Sydney University), St. Leonards, Sydney, NSW, 2065, Australia., Carr-Boyd E; Department of Pathology, Royal North Shore Hospital, St. Leonards, Sydney, NSW, 2065, Australia., Clarke SJ; Department of Medical Oncology, Royal North Shore Hospital, St. Leonards, Sydney, NSW, 2065, Australia., Itchins M; Department of Medical Oncology, Royal North Shore Hospital, St. Leonards, Sydney, NSW, 2065, Australia., Learoyd D; Genesis Care North Shore, North Shore Health Hub, Sydney, NSW, 2065, Australia., Sandanayake N; Department of Gastroenterology, Royal North Shore Hospital, St. Leonards, Sydney, NSW, 2065, Australia., Pavlakis N; Department of Medical Oncology, Royal North Shore Hospital, St. Leonards, Sydney, NSW, 2065, Australia.
Publikováno v:
Journal of medical case reports [J Med Case Rep] 2021 Oct 27; Vol. 15 (1), pp. 542. Date of Electronic Publication: 2021 Oct 27.
Calcineurin inhibitors in steroid and anti-TNF-alpha refractory immune checkpoint inhibitor colitis.
Autor:
Zhang E; Department of Gastroenterology Royal North Shore Hospital Sydney New South Wales Australia., Kiely C; Department of Gastroenterology Royal North Shore Hospital Sydney New South Wales Australia., Sandanayake N; Department of Gastroenterology Royal North Shore Hospital Sydney New South Wales Australia., Tattersall S; Department of Gastroenterology Royal North Shore Hospital Sydney New South Wales Australia.
Publikováno v:
JGH open : an open access journal of gastroenterology and hepatology [JGH Open] 2021 Mar 22; Vol. 5 (5), pp. 558-562. Date of Electronic Publication: 2021 Mar 22 (Print Publication: 2021).
Autor:
Nahar, K.J. 1, Rawson, R.V. 2, Sandanayake, N. 3, Tattersal, S. 3, Carlino, M.S. 4, Palendira, U. 5, Scolyer, R.A. 6, Long, G.V. 7, Menzies, A.M. 7
Publikováno v:
In Annals of Oncology October 2019 30 Supplement 5:v552-v552
Autor:
Nahar KJ; Melanoma Institute Australia, North Sydney, New South Wales, Australia.; Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia., Rawson RV; Melanoma Institute Australia, North Sydney, New South Wales, Australia.; Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia., Ahmed T; Melanoma Institute Australia, North Sydney, New South Wales, Australia.; Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia., Tattersall S; Gastroenterology, Royal North Shore Hospital, St Leonards, New South Wales, Australia., Sandanayake N; Gastroenterology, Royal North Shore Hospital, St Leonards, New South Wales, Australia., Kiely CJ; Gastroenterology, Royal North Shore Hospital, St Leonards, New South Wales, Australia., Lo S; Melanoma Institute Australia, North Sydney, New South Wales, Australia.; Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia., Carlino M; Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia., Palendira U; Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia., Scolyer RA; Melanoma Institute Australia, North Sydney, New South Wales, Australia.; Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Long GV; Melanoma Institute Australia, North Sydney, New South Wales, Australia.; Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia.; Medical Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.; Medical Oncology, Mater Hospital, Sydney, New South Wales, Australia., Menzies AM; Melanoma Institute Australia, North Sydney, New South Wales, Australia alexander.menzies@sydney.edu.au.; Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia.; Medical Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.; Medical Oncology, Mater Hospital, Sydney, New South Wales, Australia.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Nov; Vol. 8 (2).
Autor:
Dhar, D. K., Olde Damink, S., Brindley, J. H., Godfrey, A., Chapman, M. H., Sandanayake, N. S., Andreola, F., Mazurek, S., Hasan, T., Malago, M., Pereira, S. P.
Publikováno v:
Cancer, 119(3), 575-585. Wiley
BACKGROUND: The early diagnosis of biliary tract cancer (BTC) remains challenging, and there are few effective therapies. This study investigated whether the M2 isotype of pyruvate kinase (M2-PK), which serves as the key regulator of cellular energy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::7e963c9a0ccd29d2247454abcffb6675
https://cris.maastrichtuniversity.nl/en/publications/4609b7fc-bd77-47c5-9709-291e52bee27a
https://cris.maastrichtuniversity.nl/en/publications/4609b7fc-bd77-47c5-9709-291e52bee27a
Autor:
Huggett, M. T., Baddeley, R. N. B., Sandanayake, N. S., Webster, G. J. M., Bown, S. G., Lovat, L. B., Gillams, A., Pogue, B. W., Hasan, T., Pereira, S. P.
Publikováno v:
Proceedings of SPIE; Nov2011, Issue 1, p78860J-78860J-9, 9p